Cancer Risk

Harvard study says aspirin may lower risk of Hodgkin disease

Published in Cancer Weekly, March 9th, 2004

Scientists have found a hint that regular aspirin use might lower the risk of Hodgkin lymphoma, but more research is needed to prove it.

Even if the link is real, Hodgkin is too rare a cancer to recommend aspirin as a preventive, scientists caution, since the pills can have side effects. Instead, the research may point toward better understanding of how this cancer forms, important for future work on treatments.

Millions of Americans already take low-dose aspirin to help prevent heart attacks, and studies suggest it also may modestly lower the risk of a few cancers, most notably colon cancer.

Scientists at the Harvard School of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-03-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry